{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:48:04Z","timestamp":1792169284231,"version":"4.4.0"},"reference-count":0,"publisher":"S. Karger AG","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Addict Res"],"abstract":"<jats:p>Introduction: Despite widespread cannabis use, longitudinal evidence on quality-of-life impacts remains limited, particularly in regulated access contexts with objective purchase tracking. Methods: We conducted an 18-month longitudinal analysis of 300 participants in the [ANONYMIZED] study, a regulated cannabis access study in Switzerland. Quality of life was assessed using the EQ-5D at baseline and 18 months. Cannabis consumption was tracked objectively through pharmacy-based purchases, with additional measures of tetrahydrocannabinol (THC) content, self-reported problematic cannabis use (CUDIT-R), and self-reported consumption amount. Multiple regression analyses examined predictors of quality-of-life outcomes. Results: Overall quality of life remained stable from baseline (M=0.92, SD=0.18) to 18-month follow-up (mean change = 0.002, p=0.418). However, specific consumption patterns significantly predicted outcomes. Higher cumulative THC exposure over 18 months (b=-0.003, p=0.048), higher baseline CUDIT-R scores (b=-0.001, p=0.030), and increased self-reported consumption amount (b=-0.016, p=0.004) all independently predicted lower quality of life at follow-up. Notably, total cannabis quantity purchased through regulated channels did not predict outcomes (p=0.134). Conclusions: While regulated cannabis access does not lead to overall quality of life deterioration, THC exposure and consumption intensity\u2014rather than absolute cannabis quantity purchased\u2014are key determinants of wellbeing outcomes. These findings have important implications for harm reduction strategies and regulatory frameworks, suggesting that cannabis potency and use patterns matter more than total consumption amounts for long-term quality of life.<\/jats:p>","DOI":"10.1159\/ear\/acrag010","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:48:56Z","timestamp":1791978536000},"source":"Crossref","is-referenced-by-count":0,"title":["THC Exposure, Not Cannabis Quantity, Predicts Quality of Life Outcomes: An 18-Month Longitudinal Study of Regulated Cannabis Access in Switzerland"],"prefix":"10.1159","author":[{"given":"Jacqueline","family":"Curiger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph Felix","family":"Mosandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Guessoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Baltes-Fl\u00fcckiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"127","published-online":{"date-parts":[[2026,10,16]]},"container-title":["European Addiction Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/karger.com\/article-pdf\/doi\/10.1159\/ear\/acrag010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:01:18Z","timestamp":1792166478000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/ear\/acrag010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1159\/ear\/acrag010","archive":["Portico"],"relation":{},"ISSN":["1022-6877","1421-9891"],"issn-type":[{"value":"1022-6877","type":"print"},{"value":"1421-9891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]}}}